Rare disease clinical development is undergoing rapid transformation, driven by scientific innovation, evolving regulatory frameworks, and the need for more flexible, patient-centric trial designs. This webinar explores the current rare disease clinical development landscape and the key trends shaping its future.
Medpace experts highlight three major forces redefining how rare disease studies are designed and executed, including:
- Advantages and considerations of platform trials for rare diseases
- Emerging technologies in rare disease therapeutics, including ex vivo gene therapy
- The impact of new global regulatory frameworks such as RDEP, Fast Track IND process and incentives in China, and ultra rare considerations
Watch our on-demand webinar developed in recognition of Rare Disease Day 2026. Learn how to align innovative science with global regulatory expectations to successfully advance rare disease clinical development to drive meaningful change for patients.
Leading Rare Disease CRO | Medpace
Rare disease clinical trials present a unique set of challenges in terms of clinical trial design, regulatory strategy, site selection, patient enrollment, and project management. These trials demand a highly experienced, full-service CRO with innovative strategies to identify and engage sites and scarce patient populations, and with expertise in site and project management to achieve study aims.
Accelerate your rare disease trial by partnering with our experienced team of cross-functional experts with innovative study approaches and strong site relationships.